Nuspojave uzimanja lijekova na sluznici usne šupljine by Vanja Vučićević Boras et al.
208 Acta Clin Croat,  Vol. 54,   No. 2,  2015
Acta Clin Croat 2015; 54:208-215 Professional Paper
ADVERSE DRUG REACTIONS IN THE ORAL CAVITY
Vanja Vučićević Boras1, Ana Andabak-Rogulj2, Vlaho Brailo2, Sonja Kraljević Šimunković4, Dragana 
Gabrić3 and Danko Velimir Vrdoljak5
1Zagreb University Hospital Center; 2Department of Oral Medicine, 3Department of Oral Surgery, 4Department 
of Prosthodontics, School of Dental Medicine, University of Zagreb; 5Clinical Hospital for Tumors, 
Sestre milosrdnice University Hospital Center, Zagreb, Croatia
SUMMARY – Every medication may lead to adverse effects, even when used in standard doses 
and mode of application. In the oral cavity, adverse effects may affect every part of oral mucosa and 
are the result of medications taken either locally or systemically. Oral adverse reactions to drugs 
are not typical and therefore sometimes not easy to recognize. On diagnosing adverse side effects 
in the oral cavity, experienced clinician will usually diagnose the condition on the basis of detailed 
medical history and clinical finding. However, the only objective evidence for the offending drug 
is ‘re-challenge’, i.e. exposure to the drug after its discontinuation. It carries a huge risk of anap-
hylactic reaction; therefore it has to be performed in a controlled hospital setting. Therapy is based 
on immediate exclusion of the offending drug and, if lesions are present in the oral cavity, topical or 
systemic corticosteroid therapy is prescribed. This article gives a review of patients with oral adverse 
drug reactions referred to the Department of Oral Medicine in Zagreb.
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Introduction
Every medication may lead to adverse effects, even 
when used in standard doses and mode of application. 
Adverse effects may develop on every organ. In the 
oral cavity, adverse effects may affect every part of the 
oral mucosa and are the result of medications taken 
either locally or systemically. Adverse drug reaction 
may develop after the medication has been used once 
or after few years of continuous medication use. Oral 
adverse reactions to drugs are not typical and there-
fore sometimes not easy to recognize.
Adverse effects of systemic medications may be 
numerous, but some that are more frequent are hypos-
alivation, burning mouth symptoms, oral ulcerations, 
erythema multiforme, gingival hyperplasia, lichenoid 
reaction and angioedema1.
Fifteen years ago, we retrospectively retrieved oral 
adverse effects of the drugs that patients used and were 
referred to our Department. Most frequently, sulfon-
amides such as sulfamethoxazole and trimethoprim 
(Sinersul®), antibiotics, nonsteroidal anti-inflamma-
tory analgesics (NSAID) and propolis were the medi-
cations that induced oral adverse effects2. At the time, 
the same findings (except for propolis) were reported 
elsewhere throughout the world. 
However, it is interesting to note that this trend is 
ever changing as new drugs are marketed and others 
are withdrawn. On diagnosing adverse side effects in 
the oral cavity, experienced clinician will usually di-
agnose the condition on the basis of detailed medical 
history and clinical finding. However, the only objec-
tive evidence for the offending drug is ‘re-challenge’, 
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i.e. exposure to the drug after its discontinuation. It 
carries a huge risk of anaphylactic reaction; therefore 
it has to be performed in a controlled hospital setting. 
And the last but not the least, it is also considered un-
ethical if the offending drug can be replaced by some 
other3,4. In the past, radioallergosorbent test, baso-
phil degranulation test, as well as blastic transforma-
tion tests were performed; however, due to the huge 
number of false-positive and false-negative results, 
they are not considered accurate3. In certain cases 
when patients are taking lots of medications, detec-
tion of the offending drug is not straightforward and 
it seems prudent that a drug being already known to 
cause adverse effects is more likely to be the offend-
ing one. Therapy is based on immediate exclusion of 
the offending drug and, if lesions are present in the 
oral cavity, topical or systemic corticosteroid therapy 
is prescribed3.
Generally, there are no clinical and histopathologic 
presentations alone to relate oral adverse reactions to 
any specific medication. Many oral adverse reactions 
mimic oral lesions that are also seen in the absence of 
medication use5.
It is noteworthy that certain herbal infusions (such 
as Calendulla officinalis), herbal products (Tinctura 
adstringens), as well as some antiseptic solutions may 
lead to oral mucosal damage6. In Croatia, the use of 
propolis is quite popular. However, quite frequently 
the use of propolis leads to adverse effects in the oral 
cavity5,6. Another frequent ‘home medicine’ for oral 
use in Croatia is schnapps. From time to time, we en-
counter chemical burn/sloughing of the oral mucosa 
due to this phenomenon. A patient was referred to our 
Department due to oral lesions that were provoked by 
use of Calendulla officinalis, colloid silver and schnapps 
(Fig. 1). 
Hyposalivation
It is known that more than 500 drugs may lead 
to hyposalivation. The medications which most fre-
quently cause hyposalivation are the ones most com-
monly used, such as antihypertensives and psycho-
tropic drugs. It is known that these groups of drugs 
cause dry mouth: antihypertensives, anticholinergics, 
antihistamines, benzodiazepines, cytostatics, diuret-
ics, proton pump inhibitors and H2 antagonists, 
antipsychotics, antidepressants, hypnotics, opioids, 
muscarinic antagonists and alpha receptor agonists, 
appetite suppressors, bronchodilators, drugs for HIV 
treatment, retinoids, medications for migraine treat-
ment, decongestants, and skeletal muscle relaxants7. 
Drugs can cause parasympatholytic activity in several 
ways, including competitive inhibition of acetylcho-
line at the parasympathetic ganglia and at the effector 
junction. Drugs may also influence parasympathetic 
response indirectly via interactions with the sympa-
thetic and central nervous systems8. A patient referred 
to our Department with severe hyposalivation due to 
drug use is illustrated in Figure 2.
Fig. 1. Oral burn after rinsing with Calendulla officina-
lis, colloid silver and schnapps (source: archives of the De-
partment of Oral Medicine, School of Dental Medicine, 
University of Zagreb, Zagreb, Croatia).
Fig. 2. Severe hyposalivation due to drug use (source: ar-
chives of the Department of Oral Medicine, School of Den-
tal Medicine, University of Zagreb, Zagreb, Croatia).
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Burning Mouth Symptoms
Burning mouth symptoms are most frequently lo-
cated on the tongue and are usually a consequence of 
using angiotensin converting inhibitors (ACE) such 
as lisinopril, captopril, enalapril, etc.9. Burning symp-
toms may develop few days after the medication use 
has been initiated, but also they can appear after years 
of the drug use. When the offending drug is replaced, 
sooner or later burning symptoms will resolve. The 
mechanism by which ACE inhibitors can lead to the 
burning mouth symptoms remains unknown.
Oral Ulcerations
It is known that NSAIDs and beta blockers may 
lead to the development of oral ulceration9,10. Further-
more, sodium lauryl sulfate, which is found in most 
toothpastes, in some people can cause lesions that look 
like ulcers. Mouth ulcers can occur as side effects of 
immunosuppressive therapy. Namely, immunosup-
pressants may lead to the activation of herpes virus 
or other viruses such as cytomegalovirus, which can 
be manifested as oral ulceration. Some drugs, such 
as phenylbutazone, can cause agranulocytosis, which 
may manifest with oral ulcerations11. NSAIDs may 
cause mucosal ulceration due to local vasoconstric-
tion12. Nicorandil induced oral ulcerations are prob-
ably due to its metabolites as the onset of oral ulcer-
ations may occur weeks to months after initiation of 
nicorandil therapy. There is large individual variation 
in the levels of activity of the enzyme nicotinamide 
N-methyltransferase that catalyzes methyl conju-
gation of nicotinamide, an intermediate formed by 
denitration of nicorandil13. A few years ago, for the 
first time probably, we described a side effect of tak-
ing Spiriva (tiotropium bromide) for the treatment of 
chronic obstructive pulmonary disease that occurred 
in a patient each time when he inhaled the drug14. The 
antimetabolite drug methotrexate may also cause oral 
ulcerations (Fig. 3). Table 1 summarizes drugs most 
frequently involved in the development of oral ulcer-
ations.
Angioedema
Angioedema may develop after taking many drugs 
listed in Table 2. Drug-induced angioedema can be 
differentiated into three main categories. Firstly, im-
mediate hypersensitivity reactions to betalactam anti-
biotics constitute the most frequent allergic reactions, 
which are IgE-mediated15. Secondly, adverse reactions 
to NSAID and aspirin are generally non-allergic, in 
which inhibition of cyclooxygenase results in major 
alterations in arachidonic acid metabolism such as 
cysteinyl leukotriene overproduction15. ACE inhibi-
tors do not mediate angioedema through an allergic 
or idiosyncratic reaction; they seem to facilitate an-
Fig. 3. Ulceration due to the use of methotrexate (source: ar-
chives of the Department of Oral Medicine, School of Den-
tal Medicine, University of Zagreb, Zagreb, Croatia).
Table 1. Drug-related oral ulceration
– Antihypertensives (nicorandil, captopril, losartan)
– Antibiotics (penicillamine, vancomycin)
– Anticonvulsants (carbamazepine, phenytoin)






– Psychotropics (sertraline, olanzapine) 
Table 2. Drug-related angioedema
– ACE inhibitors (captopril, enalapril)
– Analgesics (aspirin, ibuprofen, indomethacin, 
naproxen)
– Antibiotics (penicillamine, penicillin derivatives, 
clindamycin, cephalosporins, streptomycin) and co-
trimoxazole, sulfonamides
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gioedema in predisposed individuals. The mechanism 
of angioedema with regard to ACE inhibitor therapy 
is believed to be related to the kallikrein-kinin plasma 
effector system. One hypothesis is that bradykinin, 
which is normally degraded by kininase II/ACE, ac-
cumulates in tissues15.
Gingival Hyperplasia
A well known side effect of antihypertensive drugs, 
anticonvulsants and cyclosporine is gingival hyperpla-
sia, which usually occurs several months after therapy 
with the drug has started. Hyperplasia worsens with a 
lack of oral hygiene, so frequent dental check-ups are 
recommended. Calcium channel blocker amlodipine, 
a medication used to lower blood pressure, can cause 
gingival hyperplasia (Fig. 4). Other drugs16-18 can 
lead to gingival hyperplasia less frequently and some 
are listed in Table 3. Phenytoin has been shown to 
induce gingival overgrowth by its interaction with a 
subpopulation of sensitive fibroblasts19. Cyclosporine 
has been suggested to affect the metabolic function 
of fibroblast (e.g., collagen synthesis, breakdown), 
whereas nifedipine, which potentiates the effect of cy-
closporine, reduces protein synthesis of fibroblasts20.
Erythema Multiforme
Erythema multiforme (EM) lesions can appear on 
the lips, oral mucosa and conjunctiva. Oral manifesta-
tions of EM include bullae and erosions (Fig. 5). The 
condition can also affect other mucous membranes. 
Many drugs21 can lead to the development of EM 
and the most common ones are listed in Table 4. The 
etiopathogenesis of EM is not completely understood, 
but it seems to involve a hypersensitivity reaction to 
microbial and chemical agents. It seems that oral mu-
cosa changes correspond to the ones seen in the skin 
of people affected with EM. In the beginning, epi-
dermis becomes infiltrated with CD8 T-lymphocytes 
and macrophages, whereas the dermis shows slight 
Fig. 4. Amlodipine induced gingival enlargement (source: 
archives of the Department of Oral Medicine, School of 
Dental Medicine, University of Zagreb, Zagreb, Croatia).
Table 3. Drug-related gingival swelling
– Antihypertensives (amlodipine, diltiazem, felodipine, 
lacidipin, nifedipine, verapamil)
– Antimicrobials (erythromycin) and co-trimoxazole
– Immunosuppressants (cyclosporin, interferon-alpha) 
– Psychotropics (lithium, sertraline)
– Oral contraceptives
– Anticonvulsants (lamotrigine, phenobarbitone, 
phenytoin valproate, vigabatrin)
Table 4. Drug-related erythema multiforme
– Analgesics (acetylsalicylic acid, codeine, diclofenac, 
phenylbutazone, piroxicam, tenoxicam)
– Anticonvulsants (carbamazepine, hydantoin, 
phenytoin)
– Antifungals (griseofulvin, fluconazole)
– Antihypertensives (amlodipine, digitalis, diltiazem, 
nifedipine, verapamil)
– Antimicrobials (clindamycin, chloramphenicol, 
ethambutol, penicillin derivatives, rifampicin, 
streptomycin, tetracyclines, vancomycin), co-
trimoxazole
– Diuretics (furosemide, hydrochlorothiazide, 
indapamide) 
– Hormones (minoxidil, mesterolone, progesterone) 
– Measles/mumps/rubella vaccines
– Atropine 
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influx of CD4 lymphocytes. These immunologically 
active cells are not present in sufficient numbers to be 
directly responsible for epithelial cell death. Instead, 
they release cytokines, which mediate the inflamma-
tory reaction and lead to death of epithelial cells22.
Lichenoid Reaction
The emergence of oral lichenoid reactions to the 
medication has variable latency period that can last 
from several weeks to several years from the mo-
ment when the patient started taking the offending 
drug. Probably the formation of lichenoid reactions 
depends on many factors such as the type, dosage, 
previous exposure to the drug, etc.23. Today, it is 
considered that NSAIDs and ACE inhibitors often 
lead to lichenoid reactions in the oral cavity24,25. It 
is also known that other drugs may induce oral li-
chenoid reactions (Table 5). The most reliable evi-
dence is disappearance of lichenoid reaction after 
drug discontinuation and recurrence of lesions after 
re-taking the drug, which is often difficult because of 
the risk of anaphylactic reaction1. Several years ago, 
a patient was referred to our Department and had 
lichenoid reaction to alendronate (Fosamax) (Fig. 
6). The pathogenetic mechanism of lichenoid drug 
reaction is incompletely understood. T cells, kerati-
nocytes, dendritic cells and endothelial cells, which 
express activation markers and adhesion molecules, 
are thought to be involved in the inflammatory reac-
tion that ultimately leads to apoptosis of basal kera-
tinocytes26.
Fig. 5. Erythema multiforme after taking Sinersul (sul-
famethoxazole and trimethoprim) (source: archives of the 
Department of Oral Medicine, School of Dental Medi-
cine, University of Zagreb, Zagreb, Croatia).
Fig. 6. Lichenoid reaction to alendronate (Fosamax) 
(source: archives of the Department of Oral Medicine, 
School of Dental Medicine, University of Zagreb, Zagreb, 
Croatia).
Table 5. Drug-related lichenoid reactions
– Analgesics (phenylbutazone, piroxicam)
– Antidiabetics (chlorpropamide, metformin, 
tolbutamide)
– Anticonvulsants (carbamazepine, phenytoin) 
– Antihypertensives (captopril, flunarizine, labetalol, 
methyldopa, oxprenolol, prazosin, procainamide, 
propranolol)
– Antifungals (griseofulvin, ketoconazole)
– Antimalarials (chloroquine, colchicine, dapsone, 
hydroxychloroquine, quinine)
– Antimicrobials (levamisole, lincomycin, 
metronidazole, niridazole, penicillamine, penicillins, 
prothionamide, rifampicin, streptomycin, 
sulfonamides, tetracycline)
– Drugs that act upon the central nervous system 
(amiphenazole, barbiturates, chloral hydrate, 
cinnarizine, lorazepam, lithium, phenothiazines)
– Antiplatelet activity (dipyridamole, phenindione)
– Oral contraceptives 
– Protease inhibitors
– BCG, cholera, hepatitis B vaccines
Acta Clin Croat,  Vol. 54,   No. 2,  2015 21�
Vanja Vučićević Boras et al. Oral adverse drug reactions
Oral Mucosal Pigmentations
Drugs can induce oral mucosal pigmentation. 
Most common drugs that induce oral mucosal pig-
mentations are listed in Table 6. Discoloration of oral 
mucosa also occurs with intoxication with bismuth 
(blue, brown and black), copper (green), bromine, 
gold, iron, manganese, lead and silver (gray and blue)1.
The pathogenesis of drug-induced pigmentation de-
pends on the causative drug. It can result from ac-
cumulation of melanin, deposits of the drug or one of 
its metabolites. Furthermore, some drugs may induce 
synthesis of pigments or iron can be deposited after 
damage to the blood vessels27.
Mucositis
Chemotherapeutic agents such as 5-fluorouracil 
(Fig. 7), methotrexate, bleomycin, doxorubicin, mel-
phalan and mercaptopurine may lead to the develop-
ment of mucositis28. Mucositis occurs when chemo-
therapy induces breakdown of the rapidly dividing 
epithelial cells lining the gastrointestinal tract, leaving 
the mucosal tissue open to ulceration and infection. 
During the initiation phase, chemotherapeutic agents 
lead to the generation of free radicals and DNA dam-
age29. 
Table 6. Drug-related oral mucosal pigmentation
– Analgesics (aminophenazone)
– Antihypertensives (methyldopa, propranolol, 
quinidine)
– Antimicrobials (clofazimine, doxorubicin, doxycycline, 
ketoconazole, minocycline)
– Antimalarials (chloroquine, hydroxychloroquine)
– Antiretrovirals (zidovudine)
– Chemotherapeutic agents (busulfan, 
cyclophosphamide, fluorouracil)
– Hormone-replacement therapy, contraceptives, 
diethylstilbestrol
– Psychotropic drugs (fluoxetine)
Fig. 7. Oral mucositis due to 5-fluorouracil (source: ar-
chives of the Department of Oral Medicine, School of 
Dental Medicine, University of Zagreb, Zagreb, Croa-
tia).
Fig. 8a and b. Atrophic and pseudomembranous candidiasis as a result of medication use (antibiotics and bronchodila-
tors) (source: archives of the Department of Oral Medicine, School of Dental Medicine, University of Zagreb, Zagreb, 
Croatia).
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Candidal Infection
The administration of broad-spectrum antibiot-
ics, corticosteroids, cytotoxic medications and other 
immunosuppressants may predispose patients to can-
didal infection due to alterations in commensal oral 
microflora30. It is known that oral microflora controls 
Candida levels through competition for epithelial 
cell adhesion and dietary substrates31. A large num-
ber of drugs that induce xerostomia may also influ-
ence development of candidal infection either in atro-
phic or pseudomembranous forms. Reduction in the 
amount of saliva as well as its antimicrobial salivary 
constituents (immunoglobulins, lactoferrin, histatins, 
lysozyme) may lead to increasing commensal candidal 
levels in these patients1 (Fig. 8a and b).
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Sažetak
NUSPOJAVE UZIMANJA LIJEKOVA NA SLUZNICI USNE ŠUPLJINE
V. Vučićević Boras, A. Andabak-Rogulj, V. Brailo, D. Vidović Juras, D. Gabrić, S. Kraljević Šimunković i D. V. Vrdoljak
Svaki lijek može imati neželjene nuspojave, čak i kada se koristi u terapijskim dozama i prema propisanom režimu. 
Neželjene nuspojave u usnoj šupljini mogu se pojaviti na bilo kojem dijelu oralne sluznice i mogu biti posljedica primjene 
lijeka lokalnim ili sustavnim putem. Nuspojave lijekova u usnoj šupljini nisu specifične i ponekad ih je teško prepoznati. 
Prilikom dijagnosticiranja nuspojava lijekova u usnoj šupljini iskusni liječnik obično će dijagnosticirati stanje na temelju 
detaljne povijesti bolesti i kliničkog nalaza. Međutim, jedini objektivni dokaz koji bi upućivao na uzročni lijek je tzv. re-
challenge, odnosno ponovna izloženost lijeku nakon prestanka njegove primjene. S obzirom na to da takav način testiranja 
nosi veliku opasnost od razvoja anafilaktične reakcije treba ga provesti u kontroliranim bolničkim uvjetima. Liječenje se 
temelji na trenutnom prekidu uzimanja uzročnog lijeka, a ako su prisutne lezije u usnoj šupljini ordinira se lokalna i/ili 
sustavna terapija kortikosteroidima. Ovaj pregledni članak je nastao na temelju prikaza bolesnika koji su upućeni na Zavod 
za oralnu medicinu u Zagrebu.
Ključne riječi: Farmaceutski pripravci – nuspojave; Oralne manifestacije – dijagnostika; Oralne manifestacije – terapija
